A double-blind, randomized trial on the effect of a broad-spectrum dietary supplement on key biomarkers of cellular aging including inflammation, oxidative stress, and DNA damage in healthy adults
Background: Nutritional approaches that ameliorate cellular senescence may have the potential to counteract the effects of chronic disease.
Aim: This study will investigate the effect of the Healthycell dietary supplement on markers of inflammation, oxidative stress, and DNA damage.
Methods: Thirty adults between the ages of 18 and 55 were enrolled and randomly assigned to one of the two study conditions (n=15 Healthycell and n=15 placebo). Subjects participated in a four-week intervention and were assessed at baseline, four weeks, and six weeks (after a two-week washout period).
Results: Pro-inflammatory cytokine interleukin (IL)-1α (t=2.033; mean difference=-3.97 pg/ml; SE=2.0; 95% CI: -8.0, -0.3; Cohen’s d=0.77; p=0.05) decreased, while soluble cytokine receptors sTNFR-I (t=2.057; mean difference=52.39 pg/ml; SE=18.5 95% CI: 5.2, 99.6; Cohen’s d=0.53; p=0.03) and sTNFR-II (t=1.739; mean difference=208.71 pg/ml; SE=72.0; 95% CI: 24.4, 393.0; Cohen’s d=0.61; p=0.02) increased in the treatment group versus control. C-reactive protein also rose in the Healthycell group during the trial (t=2.568; mean difference=1.41 mg/dL; SE=0.4; 95% CI: 0.3, 2.5; Cohen’s d=0.66; p<0.01), without accompanying increases in IL-6 and TNF-α. Additionally, cortisol levels decreased in the Healthycell group (t=0.575; mean difference=-0.31 ug/dL; SE=0.1; 95% CI: -0.6, -0.03; Cohen’s d=0.88; p=0.03). When groups were split by age (<35 years vs. ≥35 years), 8-hydroxydeoxyguanosine, a marker of DNA damage, decreased in the older Healthycell group compared to placebo (t=1.782; mean difference=-7.09 ng/ml; SE=3.0; 95% CI: -13.3, -0.9; Cohen’s d=0.63; p=0.03). Significant changes were also found for sTNFR-I, sTNFR-II, and IL-5 in the older group. All results were obtained from t tests by post-hoc analysis.
Conclusions: Our findings show an improved inflammatory profile and decreased DNA damage. Additionally, the efficacy of Healthycell was primarily in older adults, where the processes that cause or are associated with cell senescence are more predominant.
Relevance for patients: Healthycell may help to counteract the inflammatory effects of aging that lead to both cell senescence and the multitude of age-related chronic diseases.
[1] Weisburger J. Lifestyle, health and disease prevention: The underlying mechanisms. Eur J Cancer Prev 2002; 11: S1-7.
[2] Ogden C, Carroll M, Kit B, Flegal K. Prevalence of obesity in the united states, 2009–2010. NCHS Data Brief.
[3] World Health Organization. Cancer, 2012, 2012.
[4] Sanders T. High- versus low-fat diets in human diseases. Curr Opin Clin Nutr Metab Care 2003; 6: 151-155.
[5] Vogeli C, Shields A, Lee T, Gibson T, Marder W, Weiss K, Blumenthal D. Multiple chronic conditions: Prevalence, health consequences, and implications for quality, care management, and costs. J Gen Intern Med 2007; 22: 391-395.
[6] Kung H, Hoyert D, Xu J, Murphy X. Deaths: Final data for 2005. National Vital Statistics Reports.
[7] Bhattacharya J, Choudhry K, Lakdawalla D. Chronic disease and severe disability among working-age populations. Med Care 2008; 46: 92-100.
[8] Centers for Disease Control and Prevention. The burden of chronic diseases and their risk factors: National and state perspectives 2004. Atlanta, GA, U. S. Department Of Health and Human Services, 2004.
[9] Gonzalez C. Nutrition and cancer: The current epidemiological evidence. Br J Nutr 2006; 96: S42-S45.
[10] Anderson J, Baird P, Davis R, Jr , Ferreri S, Knudtson M, Koraym A, Waters V, Williams C. Health benefits of dietary fiber. Nutr Rev 2009; 67: 188-205.
[11] Mente A, de Koning L, Shannon H, Anand S. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2010; 169: 659-669.
[12] Krabbe K, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004; 39: 687-699.
[13] Rink L, Cakman I, Kirchner H. Altered cytokine production in the elderly. Mechanisms of ageing and development. Mech Ageing Dev 1998; 102: 199-209.
[14] Hakim F, Gress R. Immunosenescence: Deficits in adaptive immunity in the elderly. Tissue Antigens 2007; 70: 179-189.
[15] James M, Gibson R, Cleland L. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000; 71: 343S-348S.
[16] Ovadya Y, Krizhanovsky V. Senescent cells: Saspected drivers of age-related pathologies. Biogerontology 2014; 15: 627-642.
[17] Myung S, Ju W, Cho B, Oh S, Park S, Koo B, Park B. Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: Systematic review and meta-analysis of randomised controlled trials. BMJ 2013; 346: 1-22.
[18] Chowdhury R, Stevens S, Gorman D, Pan A, Warnakula S, Chowdhury S, Ward H, Johnson L, Crowe F, Hu F, Franco O. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: Systematic review and meta-analysis. BMJ 2012; 345: 1-9.
[19] Lewis J, McDaniel H, Agronin M, Loewenstein D, Riveros J, Mestre R, Martinez M, Colina N, Abreu D, Konefal J, Woolger J, Ali K. The effect of an aloe polymannose multinutrient complex on cognitive and immune functioning in alzheimer's disease. J Alzheimers Dis 2013; 33: 393-406.
[20] Lewis J, Melillo A, Tiozzo E, Chen L, Leonard S, Howell M, Diaz J, Gonzalez K, Woolger J, Konefal J, Paterson E, Barnes D. A double-blind, randomized clinical trial of dietary supplementation on cognitive and immune functioning in healthy older adults. BMC Complementary and Alternative Medicine 2014; 14
[21] Vang O, Ahmad N, Baile C, Baur J, Brown K, Csiszar A, Das D, Delmas D, Gottfried C, Lin H, Ma Q, Mukhopadhyay P,Nalini N, Pezzuto J, Richard T, Shukla Y, Surh Y, Szekeres T, Szkudelski T, Walle T, Wu J. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One 2011; 6: 1-11.
[22] Sureda A, Pons A. Arginine and citrulline supplementation in sports and exercise: Ergogenic nutrients?. Med Sport Sci 2012; 59: 18-28.
[23] Potgieter M, Pretorius E, Pepper M. Primary and secondary coenzyme q10 deficiency: The role of therapeutic supplementation. Nutr Rev 2013; 71: 180-188.
[24] Heim K, Tagliaferro A, Bobilya D. Flavonoid antioxidants: Chemistry, metabolism and structure-activity relationships. J Nutr Biochem 2002; 13: 572-584.
[25] Carocho M, Ferreira I. A review on antioxidants, prooxidants and related controversy: Natural and synthetic compounds, screening and analysis methodologies and future perspectives. Food Chem Toxicol 2013; 51: 15-25.
[26] Balasundrama N, Sundramb K, Sammana S. Phenolic compounds in plants and agri-industrial by-products: Antioxidant activity, occurrence, and potential uses. Food Chem 2006; 99: 191-203.
[27] Weseler A, Geraets L, Moonen H, Manders R, van Loon L, Pennings H, Wouters E, Bast A, Hageman G. Poly (adp-ribose) polymerase-1-inhibiting flavonoids attenuate cytokine release in blood from male patients with chronic obstructive pulmonary disease or type 2 diabetes. J Nutr 2009; 139: 952-957.
[28] Lee S, Bai S, Lee K, Namkoong S, Na H, Ha K, Han J, Yim S, Chang K, Kwon Y, Lee S, Kim Y. Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing iκb kinase-dependent nf-κb activation. Mol Cells 2003; 16: 97-105.
[29] Boadi W, Amartey P, Lo A. Effect of quercetin, genistein and kaempferol on glutathione and glutathione-redox cycle enzymes in 3t3-l1 preadipocytes. Drug Chem Toxicol 2016; 39: 239-247.
[30] Rahman K. Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 2007; 2: 219-236.
[31] Irani K, Xia Y, Zweier J, Sollott S, Der C, Fearon E, Sundaresan M, Finkel T, Goldschmidt-Clermont P. Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts. Science 1997; 275: 1649-1652.
[32] Rangel-Huerta O, Aguilera C, Martin M, Soto M, Rico M, Vallejo F, Tomas-Barberan F, Perez-de-la-Cruz A, Gil A, Mesa M. Normal or high polyphenol concentration in orange juice affects antioxidant activity, blood pressure, and body weight in obese or overweight adults. J Nutr 2015; 145: 1808-1816.
[33] Per R, Giampapa V, Vojdani A. Comparison of a broad spectrum anti-aging nutritional supplement with and without the addition of a DNA repair enhancing cat's claw extract. J Anti-Aging Med 2002; 5: 345-353.
[34] Broderick G, Katz B, Fernandes H, Fletcher M, Klimas N, Smith F, O’Gorman M, Vernon S, Taylor R. Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue. Journal of Translational Medicine 2012;10
[35] Field A. Discovering statistics using ibm spss, ed 4th. California, SAGE publications, 2013.
[36] Rao M, Mattson M. Stem cells and aging: Expanding the possibilities. Mech Ageing Dev 2001; 122: 713-734.
[37] Aubert G, Lansdorp P. Telomeres and aging. Physiol Rev 2008; 88: 557-579.
[38] Riccioni G, Speranza L, Pesce M, Cusenza S, D'Orazio N, Glade M. Novel phytonutrient contributors to antioxidant protection against cardiovascular disease. Nutrition 2012; 28: 605-610.
[39] Palacea V, Khapera N, Qina Q, Singal P. Antioxidant potentials of vitamin a and carotenoids and their relevance to heart disease. Free Radic Biol Med 1999; 26: 746-761.
[40] Esposito E, Cuzzocrea S. Tnf-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma. Curr Med Chem 2009; 16: 3152-3167.
[41] McInnes I, Leung B, Sturrock R, Field M, Liew F. Interleukin-15 mediates t cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nat Med 1997; 3: 189-195.
[42] Spoettl T, Hausmann M, Klebl F, Dirmeier A, Klump B, Hoffmann J, Herfarth H, Timmer A, Rogler G. Serum soluble tnf receptor i and ii levels correlate with disease activity in ibd patients. Inflamm Bowel Dis 2007; 13: 727-732.
[43] McDermott M. Tnf and tnfr biology in health and disease. Cell Mol Biol 2001; 47: 619-635.
[44] Opal S, DePalo V. Anti-inflammatory cytokines. Chest 2000; 117: 1162-1172.
[45] Kroese L, Scheffer P. 8-hydroxy-2′-deoxyguanosine and cardiovascular disease: A systematic review. Curr Atheroscler Rep 2014; 16:1-8.
[46] Wu L, Chiou C, Chang P, Wu J. Urinary 8-ohdg: A marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004; 339: 1-9.
[47] Chen E, Miller G. Stress and inflammation in exacerbations of asthma. Brain Behav Immun 2007; 21: 993-999.
[48] McEwen B. Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 2008; 583: 174-185
[49] Chan A, Giovannucci E, Meyerhardt J, Schernhammer E, Curhan G, Fuchs C. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 2005; 294: 914-923.
[50] Esposito K, Pontillo A, CD P, Giugliano G, Masella M, Marfella R, Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. JAMA 2003; 289: 1799-1804.
[51] Szeto Y, Timothy C, Benzie I. Effects of a long-term vegetarian diet on biomarkers of antioxidant status and cardiovascular disease risk. Nutrition 2004; 20: 863–866.
[52] World Health Organization. Keeping fit for life: Meeting the nutritional needs of older persons. Geneva, Switzerland, 2002, 2016.
[53] Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzan iA. Biomarkers of oxidative damage in human disease. Clin Chem 2006; 52: 601-623.